Clinical Trial Update: Dexamethasone/Pancreatic Clamp P&F [Phase 1]

View source ↗

Summary

The Phase 1 trial evaluating a dexamethasone-based pancreatic clamp for insulin resistance, prediabetes, NAFLD, and obesity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Non-alcoholic Fatty Liver Disease
• Obesity
• Prediabetes

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Columbia University | Conditions: Insulin Resistance, Prediabetic State | Phase 1 | Status: WITHDRAWN